Clinical Trials Directory

Trials / Conditions / Urethral Cancer Associated With Invasive Bladder Cancer

Urethral Cancer Associated With Invasive Bladder Cancer

9 registered clinical trials studyying Urethral Cancer Associated With Invasive Bladder Cancer.

StatusTrialSponsorPhase
WithdrawnGemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and
NCT01639521
University of Southern CaliforniaPhase 2
TerminatedGemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cance
NCT01611662
Fox Chase Cancer CenterPhase 2
CompletedPazopanib in Treating Patients With Metastatic Urothelial Cancer
NCT00471536
National Cancer Institute (NCI)Phase 2
CompletedGemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Functi
NCT00478361
M.D. Anderson Cancer CenterPhase 2
CompletedVEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium
NCT00407485
National Cancer Institute (NCI)Phase 2
TerminatedSorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
NCT00112905
National Cancer Institute (NCI)Phase 2
TerminatedTrastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothe
NCT00004856
National Cancer Institute (NCI)Phase 2
CompletedIxabepilone in Treating Patients With Advanced Urinary Tract Cancer
NCT00021099
National Cancer Institute (NCI)Phase 2
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1